SpringWorks Therapeutics, Inc.
NASDAQ:SWTX
33.48 (USD) • At close January 15, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 49.301 | 59.733 | 21.006 | 5.447 | 5.586 | 5.828 | 5.557 | 5.799 | 0.838 | 0.348 | 0.005 | 0 | 0.121 | 0.17 | 0.23 | 35 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 3.341 | 2.453 | 1.931 | 0.96 | 0.933 | 0.833 | 0.539 | 0.541 | 0.498 | 0.477 | 0.38 | 0.146 | 0.362 | 0.36 | 0.367 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 45.96 | 57.28 | 19.075 | 4.487 | 4.653 | 4.995 | 5.018 | 5.258 | 0.34 | -0.129 | -0.375 | -0.146 | -0.241 | -0.19 | -0.137 | 35 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.932 | 0.959 | 0.908 | 0.824 | 0.833 | 0.857 | 0.903 | 0.907 | 0.406 | -0.371 | -75 | 0 | -1.992 | -1.118 | -0.596 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 42.296 | 44.362 | 53.622 | 43.652 | 37.453 | 35.858 | 33.524 | 37.928 | 36.067 | 38.024 | 34.103 | 29.344 | 22.866 | 32.091 | 17.375 | 15.262 | 13.923 | 12.947 | 9.727 | 12.172 | 10.745 | 11.205 | 8.423 | 3.706 | 3.406 | 1.393 | 1.393 |
| General & Administrative Expenses
| 61.601 | 57.839 | 60.113 | 59.836 | 46.546 | 46.994 | 44.175 | 40.526 | 35.673 | 30.987 | 27.366 | 26.452 | 18.029 | 14.93 | 12.381 | 8.519 | 7.669 | 6.874 | 6.403 | 5.199 | 4.584 | 3.646 | 3.265 | 2.741 | 1.824 | 2.014 | 2.014 |
| Selling & Marketing Expenses
| 0 | 0 | -0.729 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 61.601 | 57.839 | 59.384 | 59.836 | 46.546 | 46.994 | 44.175 | 40.526 | 35.673 | 30.987 | 27.366 | 26.452 | 18.029 | 14.93 | 12.381 | 8.519 | 7.669 | 6.874 | 6.403 | 5.199 | 4.584 | 3.646 | 3.265 | 2.741 | 1.824 | 2.014 | 2.014 |
| Other Expenses
| 0 | 0 | 0 | 0.373 | -0.076 | -0.098 | -0.199 | 0.153 | -0.074 | -0.024 | -0.193 | -0.056 | -0.058 | -0.041 | 0.003 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 103.897 | 102.201 | 113.006 | 103.488 | 83.999 | 82.852 | 77.699 | 78.454 | 71.74 | 69.011 | 61.469 | 55.796 | 40.895 | 47.021 | 29.756 | 23.781 | 21.592 | 19.821 | 16.13 | 17.371 | 15.329 | 14.851 | 11.688 | 6.447 | 5.23 | 3.407 | 3.407 |
| Operating Income
| -57.937 | -44.921 | -93.931 | -98.463 | -83.999 | -82.852 | -77.699 | -78.454 | -71.74 | -69.011 | -61.469 | -55.796 | -40.895 | -47.021 | -29.756 | 11.219 | -21.592 | -19.821 | -16.13 | -17.371 | -15.329 | -14.851 | -11.688 | -6.447 | -5.23 | -3.407 | -3.407 |
| Operating Income Ratio
| -1.175 | -0.752 | -4.472 | -18.077 | -15.037 | -14.216 | -13.982 | -13.529 | -85.609 | -198.307 | -12,293.8 | 0 | -337.975 | -276.594 | -129.374 | 0.321 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 4.407 | 5.002 | 6.546 | 4.141 | 4.562 | 4.927 | 4.279 | 4.276 | -0.648 | -0.039 | -0.332 | -0.276 | -0.146 | 0.011 | -0.031 | 0.053 | -0.067 | -0.072 | 0.836 | 1.154 | -1.504 | 1.004 | 0.279 | 0.228 | 0.226 | 0.112 | 0.112 |
| Income Before Tax
| -53.53 | -39.919 | -87.385 | -94.322 | -79.437 | -77.925 | -73.42 | -74.178 | -72.388 | -69.05 | -61.801 | -56.072 | -41.041 | -47.01 | -29.787 | 11.272 | -21.659 | -19.893 | -15.294 | -16.217 | -16.833 | -13.847 | -11.409 | -6.219 | -5.004 | -3.295 | -3.295 |
| Income Before Tax Ratio
| -1.086 | -0.668 | -4.16 | -17.316 | -14.221 | -13.371 | -13.212 | -12.792 | -86.382 | -198.42 | -12,360.2 | 0 | -339.182 | -276.529 | -129.509 | 0.322 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0.686 | -5.603 | -5.662 | -0.382 | -4.279 | -4.276 | -0.912 | -0.372 | -0.198 | -0.081 | -0.179 | -0.211 | -0.227 | -0.174 | -0.063 | -0.157 | -0.936 | -1.267 | -0.997 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| -53.53 | -39.919 | -87.385 | -94.322 | -79.437 | -77.925 | -69.141 | -69.902 | -71.476 | -69.05 | -61.801 | -56.072 | -41.041 | -47.01 | -29.787 | 11.272 | -21.659 | -19.893 | -15.294 | -16.217 | -16.833 | -13.847 | -11.409 | -6.219 | -5.004 | -3.295 | -3.295 |
| Net Income Ratio
| -1.086 | -0.668 | -4.16 | -17.316 | -14.221 | -13.371 | -12.442 | -12.054 | -85.294 | -198.42 | -12,360.2 | 0 | -339.182 | -276.529 | -129.509 | 0.322 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.72 | -0.54 | -1.18 | -1.28 | -1.27 | -1.25 | -1.11 | -1.12 | -1.35 | -1.41 | -1.26 | -1.15 | -0.84 | -0.97 | -0.62 | 0.3 | -0.51 | -0.47 | -0.37 | -0.38 | -1.77 | -0.33 | -0.51 | -0.28 | -0.23 | -18.8 | -18.8 |
| EPS Diluted
| -0.72 | -0.54 | -1.18 | -1.28 | -1.27 | -1.25 | -1.11 | -1.12 | -1.35 | -1.41 | -1.26 | -1.15 | -0.84 | -0.97 | -0.62 | 0.3 | -0.51 | -0.47 | -0.37 | -0.38 | -1.77 | -0.33 | -0.51 | -0.28 | -0.23 | -18.8 | -18.8 |
| EBITDA
| -57.059 | -44.077 | -93.202 | -97.925 | -83.505 | -82.47 | -77.446 | -78.199 | -71.528 | -68.821 | -61.361 | -55.65 | -40.776 | -46.906 | -29.646 | 11.329 | -21.497 | -19.747 | -16.06 | -17.306 | -15.266 | -14.808 | -11.667 | -6.439 | -5.227 | -3.404 | -3.404 |
| EBITDA Ratio
| -1.157 | -0.738 | -4.437 | -17.978 | -14.949 | -14.216 | -13.937 | -13.485 | -85.356 | -197.761 | -12,272.2 | 0 | -336.992 | -275.918 | -128.896 | 0.324 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |